José A. Karam

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Daniel R. Gomez, Chad Tang, Jianjun Zhang et al. · Journal of Clinical Oncology · 2019 · 1.2K citations · Full text

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

Daniel R. Gomez, George R. Blumenschein, J. Jack Lee et al. · The Lancet Oncology · 2016 · 1.1K citations · Full text

First-line Systemic Therapy, Medicine, Cancer Management +9

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I

Steven C. Campbell, Peter E. Clark, Sam S. Chang et al. · The Journal of Urology · 2021 · 664 citations

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Lijun Zhou, Xian-De Liu, Mingli Sun et al. · Oncogene · 2015 · 386 citations · Full text

Urology, Medicine, Metronomic Therapy +8

Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

Nizar M. Tannir, Eric Jonasch, Laurence Albigès et al. · European Urology · 2015 · 356 citations · Full text

Urology, Genitourinary Cancer, Medicine +4